Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Ratain

Showing results (11-20 of 366) with videos related to

Pageof 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
The Molecular Profiling Lottery: More Accuracy, Less Precision, and No CostMark J Ratain
Nature Reviews. Clinical Oncology|August 6, 2014
Targeted therapies: redefining the primary objective of phase I oncology trialsMark J Ratain
Clinical Advances in Hematology & Oncology : H&O|July 29, 2025
Reducing drug toxicity and costs through off-label dosingMark J Ratain
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Importance of food effects for oral oncology drugsMark J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Bar the windows but open the door to randomizationMark J Ratain
Clinical Pharmacology and Therapeutics|July 13, 2019
Enhancing the Visibility and Prestige of Clinical Pharmacology as a Medical SubspecialtyMark J Ratain
Clinical Pharmacology and Therapeutics|April 12, 2024
Therapeutic Drug Monitoring of Oral Oncology Drugs: Another Example of Maslow's HammerMark J Ratain
Clinical Advances in Hematology & Oncology : H&O|November 14, 2007
The investigational drug steering committeeMark J Ratain
JCO Oncology Practice|July 14, 2022
Oncology Drug Prescribing: The Influences of Greed and FearMark J Ratain
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Casting doubt on the scientific utility of post-treatment biopsies in phase 1 trialsMark J Ratain
Pageof 37

Showing results (11-20 of 366) with videos related to

Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
The Molecular Profiling Lottery: More Accuracy, Less Precision, and No CostMark J Ratain
Nature Reviews. Clinical Oncology|August 6, 2014
Targeted therapies: redefining the primary objective of phase I oncology trialsMark J Ratain
Clinical Advances in Hematology & Oncology : H&O|July 29, 2025
Reducing drug toxicity and costs through off-label dosingMark J Ratain
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Importance of food effects for oral oncology drugsMark J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Bar the windows but open the door to randomizationMark J Ratain
Clinical Pharmacology and Therapeutics|July 13, 2019
Enhancing the Visibility and Prestige of Clinical Pharmacology as a Medical SubspecialtyMark J Ratain
Clinical Pharmacology and Therapeutics|April 12, 2024
Therapeutic Drug Monitoring of Oral Oncology Drugs: Another Example of Maslow's HammerMark J Ratain
Clinical Advances in Hematology & Oncology : H&O|November 14, 2007
The investigational drug steering committeeMark J Ratain
JCO Oncology Practice|July 14, 2022
Oncology Drug Prescribing: The Influences of Greed and FearMark J Ratain
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Casting doubt on the scientific utility of post-treatment biopsies in phase 1 trialsMark J Ratain
Pageof 37